The stock of Biotricity Inc (BTCY) has gone down by -12.16% for the week, with a -2.26% drop in the past month and a 48.62% rise in the past quarter. The volatility ratio for the week is 14.83%, and the volatility levels for the past 30 days are 13.08% for BTCY. The simple moving average for the past 20 days is -1.02% for BTCY’s stock, with a -16.72% simple moving average for the past 200 days.
Is It Worth Investing in Biotricity Inc (NASDAQ: BTCY) Right Now?
The stock has a 36-month beta value of 1.54. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BTCY is 7.89M, and at present, short sellers hold a 5.62% of that float. On April 26, 2024, the average trading volume of BTCY was 99.38K shares.
BTCY) stock’s latest price update
Biotricity Inc (NASDAQ: BTCY)’s stock price has dropped by -6.47 in relation to previous closing price of 1.39. Nevertheless, the company has seen a loss of -12.16% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-04 that After losing some value lately, a hammer chart pattern has been formed for Biotricity (BTCY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Analysts’ Opinion of BTCY
Lake Street, on the other hand, stated in their research note that they expect to see BTCY reach a price target of $5. The rating they have provided for BTCY stocks is “Buy” according to the report published on March 07th, 2022.
H.C. Wainwright gave a rating of “Buy” to BTCY, setting the target price at $6 in the report published on November 23rd of the previous year.
BTCY Trading at 5.51% from the 50-Day Moving Average
After a stumble in the market that brought BTCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.80% of loss for the given period.
Volatility was left at 13.08%, however, over the last 30 days, the volatility rate increased by 14.83%, as shares sank -4.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +46.07% upper at present.
During the last 5 trading sessions, BTCY fell by -12.16%, which changed the moving average for the period of 200-days by -47.37% in comparison to the 20-day moving average, which settled at $1.3104. In addition, Biotricity Inc saw 13.04% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for BTCY
Current profitability levels for the company are sitting at:
- -0.7 for the present operating margin
- 0.66 for the gross margin
The net margin for Biotricity Inc stands at -1.25. The total capital return value is set at 0.62.
Based on Biotricity Inc (BTCY), the company’s capital structure generated -4.15 points at debt to capital in total, while cash flow to debt ratio is standing at -0.34. The debt to equity ratio resting at -0.81. The interest coverage ratio of the stock is -1.31.
Currently, EBITDA for the company is -15.59 million with net debt to EBITDA at -2.8. When we switch over and look at the enterprise to sales, we see a ratio of 2.97. The receivables turnover for the company is 7.39for trailing twelve months and the total asset turnover is 2.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.21.
Conclusion
To sum up, Biotricity Inc (BTCY) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
